Correction to: Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Works matching IS 15588211 AND DT 2024 AND VI 19 AND IP 3
Results: 6
1
2
Treatment of Myelodysplastic Syndromes for Older Patients: Current State of Science, Challenges, and Opportunities.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 3, p. 138, doi. 10.1007/s11899-024-00733-y
- By:
- Publication type:
- Article
3
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 3, p. 120, doi. 10.1007/s11899-024-00731-0
- By:
- Publication type:
- Article
4
Management of Patients with Early Myelofibrosis: A Discussion of Best Practices.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 3, p. 111, doi. 10.1007/s11899-024-00729-8
- By:
- Publication type:
- Article
5
Tyrosine Kinase Inhibitor Discontinuation in Chronic Myeloid Leukemia: Strategies to Optimize Success and New Directions.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 3, p. 104, doi. 10.1007/s11899-024-00728-9
- By:
- Publication type:
- Article
6
Update on T-Cell Lymphoma Epidemiology.
- Published in:
- Current Hematologic Malignancy Reports, 2024, v. 19, n. 3, p. 93, doi. 10.1007/s11899-024-00727-w
- By:
- Publication type:
- Article